JPWO2018075901A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018075901A5 JPWO2018075901A5 JP2019521018A JP2019521018A JPWO2018075901A5 JP WO2018075901 A5 JPWO2018075901 A5 JP WO2018075901A5 JP 2019521018 A JP2019521018 A JP 2019521018A JP 2019521018 A JP2019521018 A JP 2019521018A JP WO2018075901 A5 JPWO2018075901 A5 JP WO2018075901A5
- Authority
- JP
- Japan
- Prior art keywords
- controlled release
- neuroprotective
- preparation
- core
- biodegradable polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000324 neuroprotective effect Effects 0.000 description 23
- 238000013270 controlled release Methods 0.000 description 16
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 10
- 229920002988 biodegradable polymer Polymers 0.000 description 9
- 239000004621 biodegradable polymer Substances 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 239000003405 delayed action preparation Substances 0.000 description 9
- 239000011247 coating layer Substances 0.000 description 6
- 239000004005 microsphere Substances 0.000 description 6
- 238000013268 sustained release Methods 0.000 description 6
- 239000012730 sustained-release form Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023016292A JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410748P | 2016-10-20 | 2016-10-20 | |
| US62/410,748 | 2016-10-20 | ||
| PCT/US2017/057606 WO2018075901A1 (en) | 2016-10-20 | 2017-10-20 | Methods of delivering a neuroprotective polypeptide to the central nervous system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Division JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020500163A JP2020500163A (ja) | 2020-01-09 |
| JP2020500163A5 JP2020500163A5 (enExample) | 2020-11-26 |
| JPWO2018075901A5 true JPWO2018075901A5 (enExample) | 2024-11-28 |
| JP7626362B2 JP7626362B2 (ja) | 2025-02-07 |
Family
ID=60382598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Active JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11273130B2 (enExample) |
| EP (2) | EP3528836A1 (enExample) |
| JP (2) | JP7626362B2 (enExample) |
| KR (2) | KR20190086460A (enExample) |
| CN (1) | CN110191717A (enExample) |
| AU (1) | AU2017345724B2 (enExample) |
| BR (1) | BR112019008021A2 (enExample) |
| CA (1) | CA3040906A1 (enExample) |
| MX (1) | MX2019004476A (enExample) |
| SG (1) | SG11201903462UA (enExample) |
| WO (1) | WO2018075901A1 (enExample) |
| ZA (1) | ZA201902486B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201903462UA (en) | 2016-10-20 | 2019-05-30 | Peptron Inc | Methods of delivering a neuroprotective polypeptide to the central nervous system |
| AU2020323820B2 (en) * | 2019-07-29 | 2024-07-18 | Peptron, Inc. | Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof |
| EP4005587A4 (en) * | 2019-07-29 | 2023-08-09 | Peptron, Inc. | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIA OR SUPPRESSION OF THEIR PROGRESSION |
| JP2023526512A (ja) * | 2020-05-22 | 2023-06-21 | トラスティーズ オブ ボストン ユニバーシティ | 線維化疾患を処置するための方法および組成物 |
| CN112014193B (zh) * | 2020-07-24 | 2021-06-15 | 武汉大学中南医院 | 一种新的fj染色方法和装置 |
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| CN116392576A (zh) * | 2023-05-26 | 2023-07-07 | 南通大学 | 一种gip受体激动剂在制备治疗脊髓损伤修复靶点药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US5609885A (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device |
| EP1249229A3 (en) | 1996-02-02 | 2005-02-02 | ALZA Corporation | Sustained delivery of an active agent using an implantable system |
| US6261584B1 (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6132420A (en) | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| ZA981610B (en) | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| MY125849A (en) | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| AU749914B2 (en) | 1997-08-08 | 2002-07-04 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds |
| EP1032587B2 (en) | 1997-11-14 | 2013-03-13 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds |
| JP4215188B2 (ja) | 1997-12-22 | 2009-01-28 | インターシア セラピューティクス，インコーポレイティド | 薬剤供給を調節するデバイスのための速度調節膜 |
| ES2217613T3 (es) | 1997-12-29 | 2004-11-01 | Alza Corporation | Sistema de liberacion osmotica con mecanismo de retencion de tapon de membrana. |
| PT1736145E (pt) | 1997-12-30 | 2012-03-16 | Intarcia Therapeutics Inc | Sistema de entrega de agente benéfico com obturador de membrana |
| ES2196918T3 (es) | 1998-12-31 | 2003-12-16 | Alza Corp | Sistema de suministro osmotico dotado de piston con economia de espacio.. |
| DK1328256T3 (da) | 1999-12-21 | 2006-02-20 | Alza Corp | Ventil til osmotiske indretninger |
| US7163688B2 (en) | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| AU2002317599B2 (en) | 2001-07-31 | 2008-04-03 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | GLP-1 exendin-4 peptide analogs and uses thereof |
| MXPA05000224A (es) | 2002-06-26 | 2005-06-03 | Alza Corp | Piston de volumen eficiente, minimamente deformable, para sistemas de suministro osmotico de farmacos. |
| US7014636B2 (en) | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| CA2520610A1 (en) | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic pump with means for dissipating internal pressure |
| US20080318837A1 (en) * | 2003-12-26 | 2008-12-25 | Nastech Pharmaceutical Company Inc. | Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide |
| US20050175701A1 (en) | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
| US9089636B2 (en) | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
| US8168222B2 (en) * | 2004-09-07 | 2012-05-01 | Board Of Regents Of The University Of Nebraska | Amphiphilic polymer-protein conjugates and methods of use thereof |
| DK2020990T3 (da) | 2006-05-30 | 2010-12-13 | Intarcia Therapeutics Inc | Strømningsmodulator med en indre kanal til et todelt osmotisk fremføringssystem |
| AU2007284759B2 (en) | 2006-08-09 | 2010-10-28 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| KR100805208B1 (ko) * | 2007-03-27 | 2008-02-21 | 주식회사 펩트론 | 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법 |
| RU2440097C2 (ru) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления |
| WO2011037623A1 (en) | 2009-09-28 | 2011-03-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
| US9259432B1 (en) * | 2011-01-31 | 2016-02-16 | Parminder J. S. Vig | Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases |
| CN103906528A (zh) | 2011-06-24 | 2014-07-02 | 安米林药品有限责任公司 | 用glp-1受体激动剂的缓释制剂治疗糖尿病的方法 |
| JP6226510B2 (ja) | 2012-01-27 | 2017-11-08 | キヤノン株式会社 | 画像処理システム、処理方法及びプログラム |
| ITMI20130325A1 (it) | 2013-03-05 | 2014-09-06 | Telecom Italia Spa | Metodo per misurare e monitorare il livello di accesso a dati personali generati da risorse di un dispositivo d'utente |
| JP2015192425A (ja) | 2014-03-28 | 2015-11-02 | 富士通株式会社 | デマンド収容変更順序決定方法、およびデマンド収容変更順序決定プログラム |
| WO2015158270A1 (zh) | 2014-04-16 | 2015-10-22 | 山东绿叶制药有限公司 | 一种含有艾塞那肽的组合物及其制备方法 |
| SG11201903462UA (en) | 2016-10-20 | 2019-05-30 | Peptron Inc | Methods of delivering a neuroprotective polypeptide to the central nervous system |
-
2017
- 2017-10-20 SG SG11201903462UA patent/SG11201903462UA/en unknown
- 2017-10-20 WO PCT/US2017/057606 patent/WO2018075901A1/en not_active Ceased
- 2017-10-20 BR BR112019008021A patent/BR112019008021A2/pt unknown
- 2017-10-20 MX MX2019004476A patent/MX2019004476A/es unknown
- 2017-10-20 KR KR1020197014421A patent/KR20190086460A/ko not_active Ceased
- 2017-10-20 EP EP17800650.8A patent/EP3528836A1/en not_active Withdrawn
- 2017-10-20 EP EP25181393.7A patent/EP4635569A2/en active Pending
- 2017-10-20 AU AU2017345724A patent/AU2017345724B2/en active Active
- 2017-10-20 US US16/342,685 patent/US11273130B2/en active Active
- 2017-10-20 CN CN201780078697.6A patent/CN110191717A/zh active Pending
- 2017-10-20 JP JP2019521018A patent/JP7626362B2/ja active Active
- 2017-10-20 CA CA3040906A patent/CA3040906A1/en active Pending
- 2017-10-20 KR KR1020217022385A patent/KR102687778B1/ko active Active
-
2019
- 2019-04-17 ZA ZA2019/02486A patent/ZA201902486B/en unknown
-
2021
- 2021-11-09 US US17/522,687 patent/US11771657B2/en active Active
-
2023
- 2023-02-06 JP JP2023016292A patent/JP2023065401A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023065401A5 (enExample) | ||
| US5716621A (en) | Nonocclusive drug delivery device and process for its manufacture | |
| RU2408368C2 (ru) | Препараты соли бупропиона с модифицированным высвобождением | |
| US8741332B2 (en) | Compositions and methods for dermally treating neuropathic pain | |
| KR930007440A (ko) | 미소립자 서방제 및 그의 제조방법 | |
| JP2001508038A (ja) | 粘膜表面および身体組織に付与可能な薬学的ゲル調製物 | |
| KR100334435B1 (ko) | 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법 | |
| RU99108461A (ru) | Лекарственная форма для перорального введения с отложенным немедленным высвобождением и способ ее приготовления | |
| JP2010531343A (ja) | 生分解性パッチ | |
| JP2010519253A (ja) | 組換えゼラチンを含む制御放出組成物 | |
| JP2002536319A (ja) | 局所用スプレー | |
| JPH07187994A (ja) | 薬物放出制御製剤 | |
| WO2004026262A3 (en) | Abuse-resistant pharmaceutical compositions | |
| KR20040036928A (ko) | 약물 전달 시스템 | |
| DE60124294D1 (de) | Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe | |
| JPWO2018075901A5 (enExample) | ||
| JP2008512411A (ja) | 接着剤層を含む経皮治療システム、このシステムの支持層をシリコン処理する方法およびこの支持層の使用 | |
| CN100536834C (zh) | 多层经粘膜治疗系统 | |
| JP2008507495A (ja) | 活性本体の経皮送達用デバイス | |
| KR101333100B1 (ko) | 폴리우레탄 군으로부터의 필름-형성 헤어 케어 폴리머의 용도 및 폴리머를 포함하는 약학적 제제와 패치 | |
| RU2220714C2 (ru) | Единичная твердая дозированная форма рапамицина для орального применения (варианты), способ ее получения | |
| KR970058724A (ko) | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 | |
| WO2001013898A3 (en) | Pharmaceutical formulations with different release times | |
| KR20140013436A (ko) | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 | |
| JPH02292228A (ja) | 固体ゲル外用薬剤送達システム |